Category: Health Canada News
-
New Warning About Severe Liver Problems Due To Ketek
Hepatotoxicity Risks Noted In September 2006 "Dear Doctor" Letter On October 4, 2006 Health Canada issued a MedEffect alert to let doctors and patients know that the drug company Sanofi-aventis Canada is updating its…
-
Anti-Epileptic Drugs Associated With Birth Defects And Fetal Death
Study Looks At Depakote, Dilantin, Tegretol, And Lamictal An August 8, 2006 article in the Los Angeles Times (LA Times) reports about a recent study involving four popular epilepsy drugs which found that one…
-
Association of Sudden Vision Loss / NAION With Erectile Dysfunction (ED) Drugs
A "Dear Doctor" Letter Was Sent In June 2006, But Only In Canada As reported previously, the erectile dysfunction (ED) drugs Cialis (tadalafil), Levitra (vardenafil hydrochloride), and Viagra (sildenafil citrate) have been associated with…
-
Health Canada Issues Pregnancy Warning For Antidepressants
Newborns Whose Mothers Took SSRIs At Increased Risk Of Serious Lung Disorder On March 10, 2006 Health Canada issued a warning for women taking antidepressant drugs known as Selective Serotonin Re-uptake Inhibitors (SSRIs) —…
-
FDA Reviewing Safety Of Bayer’s Heart Surgery Drug Trasylol
Studies Link Trasylol To Kidney Problems, Heart Attacks, and Strokes In mid-February 2006 the FDA issued a Public Health Advisory informing doctors and patients that the agency was evaluating the safety of Bayer AG’s…
-
Adderall Safety Is Not Proven By Health Canada’s Decision To Reverse Ban On ADHD Drug
A Closer Look At How (Or Why) Adderall Got Back On The Market In Canada In the October 7, 2005 edition of Psychiatric News there was an article by Jim Rosack entitled "Canada Reverses…
-
Bextra Will Not Return In Canada As Safety Risks Outweigh Benefits
Health Canada Safety Panel Cites Heart Attacks, Strokes, and Severe Skin Reactions Bextra, Pfizer’s anti-inflammatory drug for arthritis patients, will not be returned to the Canadian market according to a Health Canada announcement in…
-
Serevent, Advair, and Foradil: Increased Risk of Severe Asthma Episodes and Death
FDA MedWatch Alert About LABA Asthma Drugs Follows Health Canada Warning In October 2005 On November 18, 2005 the FDA issued a MedWatch alert regarding Serevent, Advair, and Foradil to inform doctors and patients…
-
Health Canada Put Adderall Back on the Market Based on “Inconclusive Evidence”
Safety of Adderall Cannot be Adequately Evaluated Says Expert Committee Chairman In the October 11, 2005 edition of the Canadian Medical Association Journal ("CMAJ"), an article by Wayne Kondro reveals that Health Canada reintroduced…
-
Pfizer Agrees to New Celebrex Safety Guidelines in Canada
Health Canada Revisions to Celebrex Label Accepted by Pfizer Canada On September 21, 2005 Pfizer Canada announced the drug company had agreed to make changes suggested by Health Canada that add new safety guidelines…